Results 51 to 60 of about 162,041 (218)

Heterozygous laminin β2 mutation in C3 glomerulopathy

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2021
C3 glomerulopathy is usually seen with the presence of C3 nephritic factor, homozygous or heterozygous mutations in the regulatory complement proteins factor H, factor I, or C3. We describe the presence of heterozygous laminin β2 mutation in a patient of
Manish R Balwani   +3 more
doaj   +1 more source

C3 glomerulopathy associated with both hypertensive retinopathy and purtscher-like retinopathy

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: This article reports the case of a 21-year-old woman with both hypertensive retinopathy and Purtscher-like retinopathy in association with C3 glomerulopathy.
Moosa Zaidi   +8 more
doaj   +1 more source

Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report

open access: yesBMC Nephrology, 2018
Background Complement component 3 (C3) glomerulopathy, which includes dense deposit disease (DDD) and C3 glomerulonephritis, is caused by dysregulation of the alternative complement pathway.
Shuma Hirashio   +7 more
doaj   +1 more source

Recurrence of rare disease after kidney transplant [PDF]

open access: yesJournal of Nephropharmacology, 2023
The incidence of chronic kidney diseases (CKDs) by rare etiologies is growing along with other CKDs. This mini-review discusses the epidemiology, pathogenesis, clinical presentation, and diagnosis of rare kidney disease recurrence after kidney ...
Farahnoosh Farnood   +4 more
doaj   +1 more source

A new complement factor B mutation associated with crescentic C3 glomerulopathy; a case report [PDF]

open access: yesJournal of Nephropathology, 2019
Background: C3 glomerulopathy is a recently described entity classified as complementassociated glomerular disease. Case Presentation: We report a case of a 48-year-old man referred to the nephrology department for nephrotic syndrome with rapidly ...
Sofia Semedo Coelho   +10 more
doaj   +1 more source

Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases

open access: yesKidney International Reports, 2023
Introduction Dysregulated complement activation is likely the primary driver of disease in C3 glomerulopathy (C3G) and contributes to other complement-mediated diseases, including immunoglobulin A nephropathy (IgAN), lupus nephritis (LN), and primary ...
B. Dixon   +6 more
semanticscholar   +1 more source

C4d at Crossroads Between Post-Infectious Glomerulonephritis and C3 Glomerulopathy

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2021
Shaarif Bashir,1 Mudassar Hussain,1 Aurangzeb Afzal,2 Usman Hassan,1 Maryam Hameed,1 Sajid Mushtaq1 1Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, 54000, Pakistan; 2Department of Nephrology, Lahore General ...
Bashir S   +5 more
doaj  

Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein

open access: yesFrontiers in Immunology, 2021
The impairment of the alternative complement pathway contributes to rare kidney diseases such as atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G).
Aleksandra Urban   +15 more
doaj   +1 more source

C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes [PDF]

open access: yes, 2021
BACKGROUND AND OBJECTIVES: Membranoproliferative GN and C3 glomerulopathy are rare and overlapping disorders associated with dysregulation of the alternative complement pathway.
Wilson, V   +24 more
core  

Home - About - Disclaimer - Privacy